Increasing aspirin prescriptions for high-risk pregnant women
Aspirin Prescription For Moderate- and High-Risk Obstetric Population in Outpatient Clnic; A Quality Improvement Project.
Cairo University · NCT06694233
This study is trying to see if more doctors will prescribe low-dose aspirin to pregnant women at risk of preeclampsia to help prevent this serious condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Sex | Female |
| Sponsor | Cairo University (other) |
| Locations | 1 site (Hadiya, Ahmadi) |
| Trial ID | NCT06694233 on ClinicalTrials.gov |
What this trial studies
This observational study aims to improve the rates of aspirin prescriptions among outpatient clinics for women at moderate to high risk of developing preeclampsia. Preeclampsia is a serious condition that can arise during pregnancy, and low-dose aspirin has been shown to significantly reduce its occurrence and related adverse outcomes. The study will audit current prescription practices and implement strategies to ensure that eligible patients receive aspirin as a preventive measure. The focus is on women with specific risk factors, including previous hypertensive diseases, chronic conditions, and certain demographic factors.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women with moderate to high risk factors for preeclampsia, such as a history of hypertensive disease or chronic health conditions.
Not a fit: Patients who are not at risk for preeclampsia or those who do not meet the eligibility criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to increased aspirin use, thereby reducing the incidence of preeclampsia and improving pregnancy outcomes for high-risk women.
How similar studies have performed: Previous studies have demonstrated the effectiveness of low-dose aspirin in reducing preeclampsia rates, indicating that this approach has been successful in similar contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Women at high risk are those with any of the following: 1. hypertensive disease during a previous pregnancy 2. chronic kidney disease 3. autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome 4. type 1 or type 2 diabetes 5. chronic hypertension. Women with more than one moderate risk factor, such as are: 1. nulliparity 2. age 40 years or older 3. pregnancy interval of more than 10 years 4. body mass index (BMI) of 35 kg/m2 or more at first visit 5. family history of pre-eclampsia 6. multi-fetal pregnancy. Exclusion Criteria: * None. All eligible candidates will be included.
Where this trial is running
Hadiya, Ahmadi
- Adan hospital — Hadiya, Ahmadi, Kuwait (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Low Birth Weight, Small for Gestational Age, Preeclampsia, Prevention &Amp, Control, Aspirin, obstetric, risk population